Intellia Therapeutics, Inc.

NTLANASDAQNASDAQ Global Market·USD·Closed

$13.15

−$0.75 (5.40%)

$13.15

−$0.75 (5.40%)

Healthcare · Biotechnology

52W Range

32thpercentile

Mid-range

Volume

5.27M

Market Cap

1.52BUSD

Small-cap company

P/E Ratio

-TTM

Div Yield

-annual

No dividend

The signals we see for NTLA lean cautious.

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required